Waiving COVID vaccine patent rights? It’s complicated
Harvard Law Today recently spoke to Professors Terry Fisher and Ruth Okediji about COVID-19 vaccine challenges in the global south, waiving drug-maker patents, and what they propose to reform the system in time for the next pandemic.